Erasca Inc (ERAS) concluded trading on Thursday at a closing price of $2.45, with 3.75 million shares of worth about $9.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.11% during that period and on December 19, 2024 the price saw a loss of about -1.61%. Currently the company’s common shares owned by public are about 282.69M shares, out of which, 163.43M shares are available for trading.
Stock saw a price change of -6.84% in past 5 days and over the past one month there was a price change of -12.19%. Year-to-date (YTD), ERAS shares are showing a performance of 15.02% which increased to 24.37% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.64 but also hit the highest price of $3.45 during that period. The average intraday trading volume for Erasca Inc shares is 1.74 million. The stock is currently trading -12.62% below its 20-day simple moving average (SMA20), while that difference is down -12.49% for SMA50 and it goes to -3.50% lower than SMA200.
Erasca Inc (NASDAQ: ERAS) currently have 282.69M outstanding shares and institutions hold larger chunk of about 56.34% of that.
The stock has a current market capitalization of $692.68M and its 3Y-monthly beta is at 1.22. It has posted earnings per share of -$0.83 in the same period. It has Quick Ratio of 11.00 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ERAS, volatility over the week remained 6.34% while standing at 7.54% over the month.
Stock’s fiscal year EPS is expected to rise by 10.85% while it is estimated to increase by 17.99% in next year. EPS is likely to grow at an annualized rate of -4.10% for next 5-years, compared to annual growth of -69.36% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on November 18, 2024 offering a Buy rating for the stock and assigned a target price of $6 to it. Coverage by CapitalOne stated Erasca Inc (ERAS) stock as an Overweight in their note to investors on March 11, 2024, suggesting a price target of $8 for the stock. On January 05, 2024, BofA Securities Downgrade their recommendations, while on October 11, 2023, H.C. Wainwright Initiated their ratings for the stock with a price target of $10. Stock get a Buy rating from Mizuho on March 30, 2023.
